Related Experiment Video
Updated: Jan 13, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Chronic methylphenidate abuse: Effects on behaviour, redox homeostasis, and cholinergic system
Natália Freddo1, Jéssica Nardi2, Wagner Antonio Tamagno3
1Programa de Pós-Graduação em Bioexperimentação, Universidade de Passo Fundo, BR 285, São José, Passo Fundo, Rio Grande do Sul, Brazil.
Abusive methylphenidate (MPH) use in adults without ADHD causes anxiety, fear, and memory deficits. This drug abuse alters biochemical markers, cortisol, and the cholinergic system, leading to significant damage.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- Methylphenidate (MPH) is misused as a cognitive enhancer due to its amphetamine-like structure.
- Understanding the neurobiological effects of chronic, high-dose MPH exposure is crucial.
Purpose of the Study:
- To investigate behavioral and biochemical alterations in zebrafish following chronic, abusive methylphenidate exposure.
- To elucidate the mechanisms underlying MPH toxicity in non-ADHD individuals.
Main Methods:
- Adult zebrafish (Danio rerio) were exposed to a high dose of MPH (80 mg/L/day for 7 days).
- Behavioral tests assessed locomotion, anxiety, fear, and memory.
- Biochemical analyses measured antioxidant enzymes, thiols, reactive oxygen species, cortisol, and cholinergic markers.
Main Results:
- MPH exposure induced hypolocomotion, anxiety-like behavior, fear responses, and memory impairment.
- Increased levels of antioxidant enzymes, non-protein thiols, and reactive oxygen species were observed.
- Reduced cholinergic signaling and elevated cortisol levels indicated neurochemical disruption.
Conclusions:
- Chronic abusive methylphenidate use causes significant behavioral and neurochemical changes.
- The study clarifies mechanisms of MPH toxicity, highlighting potential damage in individuals without ADHD.
- Findings underscore the risks associated with non-prescribed, high-dose MPH administration.
More Related Videos
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Drugs Affecting Neurotransmitter Synthesis
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Drug Abuse and Addiction: Pharmacological Phenomena
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...